SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024219
Filing Date
2022-11-10
Accepted
2022-11-10 09:16:29
Documents
65
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tngx-20220930.htm   iXBRL 10-Q 3498070
2 EX-31.1 tngx-ex31_1.htm EX-31.1 20536
3 EX-31.2 tngx-ex31_2.htm EX-31.2 20402
4 EX-32.1 tngx-ex32_1.htm EX-32.1 10008
5 EX-32.2 tngx-ex32_2.htm EX-32.2 9996
  Complete submission text file 0000950170-22-024219.txt   9802759

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tngx-20220930_pre.xml EX-101.PRE 298392
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tngx-20220930_def.xml EX-101.DEF 208782
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tngx-20220930.xsd EX-101.SCH 47788
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tngx-20220930_cal.xml EX-101.CAL 45020
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tngx-20220930_lab.xml EX-101.LAB 404977
59 EXTRACTED XBRL INSTANCE DOCUMENT tngx-20220930_htm.xml XML 1735870
Mailing Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142
Business Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39485 | Film No.: 221375282
SIC: 2834 Pharmaceutical Preparations